Literature DB >> 7207512

Mechanism of factor X deficiency in systemic amyloidosis.

B Furie, L Voo, K P McAdam, B C Furie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7207512     DOI： 10.1056/NEJM198104023041407

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  25 in total

1.  Prolonged PT and aPTT in a patient with severe proteinuria.

Authors:  Irene Motta; Andrea Artoni; Margherita Migone De Amicis; Cinzia Hu; Maria Domenica Cappellini
Journal:  Intern Emerg Med       Date:  2013-08-09       Impact factor: 3.397

2.  Sicca syndrome as an initial symptom of amyloidosis.

Authors:  D Jardinet; R Westhovens; J Peeters
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

3.  Hereditary Factor X (Stuart-Prower Factor) Deficiency.

Authors:  P K Gupta; H Kumar; S Kumar
Journal:  Med J Armed Forces India       Date:  2011-07-21

4.  Use of prothrombin complex concentrate for prophylaxis of bleeding in acquired factor X deficiency associated with light-chain amyloidosis.

Authors:  Dino Veneri; Anna C Giuffrida; Angela Bonalumi; Stefano Calabria; Giorgio Gandini; Achille Ambrosetti; Pietro Minuz
Journal:  Blood Transfus       Date:  2016-05-24       Impact factor: 3.443

5.  Factoring in the missing link.

Authors:  Nilay Sethi; Reza Sedighi Manesh; Adam Sperling; Scott C Bresler; Nathan T Connell; Lawrence M Tierney
Journal:  Am J Hematol       Date:  2016-08-22       Impact factor: 10.047

6.  Intracellular immunoglobulin distribution of bone marrow plasma cells as a diagnostic aid for primary amyloidosis.

Authors:  C Thielemans; W Aelbrecht; D Verbeelen; G Somers; M De Waele; B Van Camp
Journal:  J Clin Pathol       Date:  1982-03       Impact factor: 3.411

Review 7.  Hemostatic changes in patients with malignancy.

Authors:  G H Goldsmith
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

8.  Reversible functional asplenia and subcapsular liver hematoma--two distinctive manifestations of amyloidosis.

Authors:  E Levy-Lahad; D Steiner-Salz; N Berkman; R Chisin; P Levensart; E Leitersdorf
Journal:  Klin Wochenschr       Date:  1987-11-16

Review 9.  Laboratory evaluation of a bleeding patient.

Authors:  R O Wallerstein
Journal:  West J Med       Date:  1989-01

10.  Systemic AL amyloidosis with acquired factor X deficiency: A study of perioperative bleeding risk and treatment outcomes in 60 patients.

Authors:  Carrie A Thompson; Robert Kyle; Morie Gertz; John Heit; Rajiv Pruthi; Animesh Pardanani
Journal:  Am J Hematol       Date:  2010-03       Impact factor: 10.047
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.